Automatic Website Traffic Generator


US   France   Germany   Spain   Netherlands  

DEA Designates Syndros as Schedule II Drug | Latest News

DEA Designates Syndros as Schedule II Drug

Insys Therapeutics announced that the Drug Enforcement Agency (DEA) has issued an interim final rule that would lead to Syndros (dronabinol oral solution) being categorized as a Schedule II drug. Syndros is an orally-administered liquid formulation of the ... read more

DEA Approves Synthetic Cannabis “Syndros” As Schedule II

as Schedule II. The DEA has designated Syndros, a synthetic THC drug, with the status of Schedule II in relation to the Controlled Substances Act (CSA). Syndros is a medicine derived from Insys’ synthetic cannabis. The objective is to have cannabis ... read more

DEA awards Schedule II classification to synthetic THC drug

the FDA recommended to the DEA to schedule Syndros as a Schedule II drug. Syndros uses a synthetic version of tetrahydrocannabinol (THC), the compound associated with the psychoactive effects of cannabis, unlike other cannabis extracts, such as cannabidiol ... read more

$INSY DEA Schedules Syndros (dronabinol oral solution) as Schedule II Drug

(“Insys” or the “Company”) today announced that the Drug Enforcement Agency (“DEA”) has issued an interim final rule that would result in Syndros™ (dronabinol oral solution) being placed in Schedule II of the Controlled Substances A read more

DEA Approves Syndros, a Pharma Cannabis Solution, for Schedule II Status

The Drug Enforcement Administration has awarded a Schedule II classification for a cannabis solution ... The pharmaceutical drug company Insys waited two years for the approval of Syndros, an oral remedy containing THC; this week the DEA finally gave ... read more

DEA Classifies Synthetic THC Drug As Schedule II

the synthetic THC-substitute––the Drug Enforcement Administration classified Syndros as Schedule II under the Controlled Substances Act. The DEA designation has Syndros in a class of drugs considered to be less dangerous than actual weed. And the ... read more

DEA Schedules Insys Therapeutics’ Syndros (dronabinol oral solution) as Schedule II Drug

(„Insys” or the “Company”) today announced that the Drug Enforcement Agency (“DEA”) has issued an interim final rule that would result in Syndros™ (dronabinol oral solution) being placed in Schedule II of the Controlled Substances A read more
Popular RSS Feeds: talk to sonic software configuration management answering service before and after pictures plastic wristbands joan bennett carne deshebrada grey college bond funds calories in a satsuma hardin library eso server status skunk cabbage how to become a counselor frcp 45 uea portal certificats house buyers loews corp winston salem weather thor equities car extended warranty


Buy AutoTrafficRSS script now for $27 only!

We will send the script to your PayPal email within few hours,
Please add FullContentRSS@gmail.com to your email contact.



Auto Traffic generator Powered by. Full RSS Feed | Article Generator | Contact Us